Gosset Ownership
Private
Therapeutic Areas
Stage
Preclinical
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
VantAI General Information
VantAI uses generative AI and machine learning to discover novel therapeutics, particularly focusing on protein degraders and molecular glues. No clinical results reported yet.
Contact Information
Website
Primary Industry
Drug Discovery Services
Corporate Office
New York, New York
United States
United States
Drug Pipeline
No pipeline data available
Key Partnerships
Janssen Pharmaceutical (Johnson & Johnson), Boehringer Ingelheim, Bristol Myers Squibb
VantAI Funding
No funding data available
To view VantAI's complete valuation and funding history, request access »